vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v17i4.1917vsp-1921Research ArticleНЕПРЕРЫВНОЕ ПРОФЕССИОНАЛЬНОЕ ОБРАЗОВАНИЕPROFESSIONAL DEVELOPMENTХордома: этиология, патогенез, диагностика, лечениеChordoma: Etiology, Pathogenesis, Diagnosis, TreatmentТравкинаЮ. В.TravkinaJulia V.https://orcid.org/0000-0003-4295-7436ЖевакТ. Н.ZhevakTatiana N.https://orcid.org/0000-0003-0151-9114ЛитвицкийП. Ф.LitvitskyPeter F.

Литвицкий Пётр Францевич, доктор медицинских наук, профессор, заведующий кафедрой патофизиологии

119992, Москва, ул. Трубецкая, д. 8

litvicki@mma.ruПервый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)РоссияSechenov First Moscow State Medical University (Sechenov University)Russian Federation201803102018174266271Copyright © Травкина Ю.В., Жевак Т.Н., Литвицкий П.Ф., 20182018Травкина Ю.В., Жевак Т.Н., Литвицкий П.Ф.Travkina J.V., Zhevak T.N., Litvitsky P.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1921

В лекции анализируются современные сведения об этиологии, ключевых звеньях патогенеза, клинических проявлениях, видах, методах диагностики и лечения опухоли из клеток нотохорды — хордомы. Для оценки уровня усвоения материала лекции приведены ситуационная задача и тестовые вопросы с вариантами правильных ответов.

The lecture analyzes modern knowledge about etiology, key mechanisms of pathogenesis, clinical manifestations, types, diagnostic methods and treatment strategy of chordoma (tumor from notochordal cells). To assess the retention of the lecture material, a case problem and multiple-choice test questions are given.

хордомапатогенезатипизм клетокбелок brachyurychordomapathogenesisatypia of cellsprotein brachyuryНе указанNot specifiedReferencesGenetics home reference [Internet]. Chordoma: National library of medicine’s (US). [cited 2018 Aug 8] Available from: https://ghr. nlm.nih.gov/condition/chordoma#.Genetics home reference [Internet]. Chordoma: National library of medicine’s (US). [cited 2018 Aug 8] Available from: https://ghr. nlm.nih.gov/condition/chordoma#.Сидоркин Д.В., Коновалов А.Н. , Махмудов У.Б., и др. Топографические варианты краниальных хордом // Вопросы нейрохирургии им. Н.Н. Бурденко. — 2009. — № 3 — С. 14–18.Sidorkin DV, Konovalov АN, Makhmudov UB, et al. Topographic variants of cranial chordomas. Zh Vopr Neirokhir Im N N Burdenko. 2009;(3):14–18. (In Russ).Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188–193. doi: 10.1200/JCO.2017.75.1743.Whelan JS, Davis LE. Osteosarcoma, chondrosarcoma, and chordoma. J Clin Oncol. 2018;36(2):188–193. doi: 10.1200/JCO.2017.75.1743.Davies JA. Life unfolding: how the human body creates itself. Oxford, UK: Oxford University Press; 2014. 299 p.Davies JA. Life unfolding: how the human body creates itself. Oxford, UK: Oxford University Press; 2014. 299 p.Nibu Yu, Josй-Edwards DS, Di Gregori A. From notochord formation to hereditary chordoma: the many roles of Brachyury. Biomed Res Int. 2013;2013:826435. doi: 10.1155/2013/826435.Nibu Yu, Josй-Edwards DS, Di Gregori A. From notochord formation to hereditary chordoma: the many roles of Brachyury. Biomed Res Int. 2013;2013:826435. doi: 10.1155/2013/826435.rarediseases.org [Internet]. Chordoma [cited 2018 Aug 8]. Available from: https://rarediseases.org/rare-diseases/chordoma/rarediseases.org [Internet]. Chordoma [cited 2018 Aug 8]. Available from: https://rarediseases.org/rare-diseases/chordoma/.Daland EM. Chordoma. Bost Med Surg J. 1919;180:571–576. doi: 10.1056/NEJM191905221802102.Daland EM. Chordoma. Bost Med Surg J. 1919;180:571–576. doi: 10.1056/NEJM191905221802102.Roy S. Pathology of Chordoma [Internet]. India: © HistopathologyIndia.net [cited 2018 Aug 10]. Available from: http://www.histopathology-india.net/chordoma.htmRoy S. Pathology of Chordoma [Internet]. India: © HistopathologyIndia.net [cited 2018 Aug 10]. Available from: http://www.histopathology-india.net/chordoma.htmStacchiotti S, Sommer J; Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 2015;16(2): е71–83. doi: 10.1016/S1470-2045(14)71190-8.Stacchiotti S, Sommer J; Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 2015;16(2): е71–83. doi: 10.1016/S1470-2045(14)71190-8.Глыбочко П.В., Попков В.М., Бабушкина И.В. и др. Канцерогенез: патофизиологические и клинические аспекты. — Саратов: СГМУ; 2011. — С. 7–90.Glybochko PV, Popkov VM, Babushkina IV, et al. Kantserogenez: patofiziologicheskie i klinicheskie aspekty. Saratov: Saratov State Medical University Press; 2011. pp. 7–90. (In Russ).Онкология / Под ред. Чиссова В.И., Дарьяловой С.Л. — М.: ГЭОТАР-Медиа; 2007. — С. 269–274.Oncology. Ed by Chissov V.I., Dar'yalova S.L. Moscow: GEOTАR-Media; 2007. pp. 269–274. (In Russ).Заридзе Д.Г. Канцерогенез. — М.: Медицина; 2004. — 576 с.Zaridze DG. Carcinogenesis. Moscow: Meditsina; 2004. 576 р. (In Russ).]Копнин Б.П. Современные представления о механизмах злокачественного роста: сходства и различия солидных опухолей и лейкозов // Клиническая онкогематология. — 2012. — Т. 5. — № 3 — С. 165–185.Kopnin BP. Modern concepts of the mechanisms of tumor growth: similarities and differences between solid tumors and leukemia. Klinicheskaya onkogematologiya. 2012;5(3):165–185. (In Russ).Sun X, Hornicek F, Schwab JH. Chordoma: an update on the pathophysiology and molecular mechanisms. Curr Rev Musculoskelet Med. 2015;8(4):344–352. doi: 10.1007/s12178-015-9311-x.Sun X, Hornicek F, Schwab JH. Chordoma: an update on the pathophysiology and molecular mechanisms. Curr Rev Musculoskelet Med. 2015;8(4):344–352. doi: 10.1007/s12178-015-9311-x.Boguski MS, Mc Cormick F. Proteins regulating Ras and its relatives. Nature. 1993;366(6456):643–654. doi: 10.1038/366643a0.Boguski MS, Mc Cormick F. Proteins regulating Ras and its relatives. Nature. 1993;366(6456):643–654. doi: 10.1038/366643a0.Chen KW, Yang HL, Lu J, et al. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. J Neurooncol. 2011;101(3):357–363. doi: 10.1007/s11060010-0263-0.Chen KW, Yang HL, Lu J, et al. Expression of vascular endothelial growth factor and matrix metalloproteinase-9 in sacral chordoma. J Neurooncol. 2011;101(3):357–363. doi: 10.1007/s11060010-0263-0.Shalaby A, Presneau N, Ye H, et al. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol. 2011;223(3):336–346. doi: 10.1002/path.2818.Shalaby A, Presneau N, Ye H, et al. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target. J Pathol. 2011;223(3):336–346. doi: 10.1002/path.2818.Вельков В.В. NGAL — «ренальный тропонин», ранний маркер острого повреждения почек: актуальность для нефрологии и кардиохирургии // Клинико-лабораторный консилиум. — 2011. — № 2 — С. 90–100.Vel’kov VV. NGAL — «renal’nyi troponin», rannii marker ostrogo povrezhdeniya pochek: aktual’nost’ dlya nefrologii i kardiokhirurgii. Kliniko-laboratornyi konsilium. 2011;(2):90–100. (In Russ).chordomafoundation.org [Internet]. Chordoma Foundation [cited 2018 Aug 19]. Available from: https://www.chordomafoundation.org.chordomafoundation.org [Internet]. Chordoma Foundation [cited 2018 Aug 19]. Available from: https://www.chordomafoundation.org.Huang J, Manning BD. Manning The TSC1–TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008; 412(2):179–190. doi: 10.1042/BJ20080281.Huang J, Manning BD. Manning The TSC1–TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 2008; 412(2):179–190. doi: 10.1042/BJ20080281.Fisher MC, Stone JH, Palmer WE. Case records of the Massachusetts General Hospital. Case 31-2014. A 50-year-old man with back pain, fatigue, weight loss, and knee swelling. N Engl J Med. 2014;371(15):1447–1455. doi: 10.1056/NEJMcpc1404517.Fisher MC, Stone JH, Palmer WE. Case records of the Massachusetts General Hospital. Case 31-2014. A 50-year-old man with back pain, fatigue, weight loss, and knee swelling. N Engl J Med. 2014;371(15):1447–1455. doi: 10.1056/NEJMcpc1404517.Скопичев В.Г. Изменение уровня молекул средней массы и эхиноцитоз при лучевой болезни и интоксикациях // Вестник Новгородского государственного университета им. Ярослава Мудрого. — 2015. — № 3–1 — С. 76–79.Skopichev VG. The change of the level of medium-weight molecules and the echinocytosis under the radiation sickness and the intoxications. Vestnik Novgorodskogo gosudarstvennogo universiteta im. Yaroslava Mudrogo. 2015;(3–1):76–79. (In Russ).Проценко Г.А. Паранеопластические синдромы в ревматологической практике // Український ревматологічний журнал. — 2016. — № 63 — С. 33–37.Protsenko GA. Paraneoplastic syndromes in rheumatological practice. Ukrainian journal of rheumatology. 2016;(63):33–37. (In Russ).Fenerty KE, Folio LR, Patronas NJ, et al. Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST. BMC Cancer. 2016;16(1):672. doi: 10.1186/s12885-016-2699-x.Fenerty KE, Folio LR, Patronas NJ, et al. Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST. BMC Cancer. 2016;16(1):672. doi: 10.1186/s12885-016-2699-x.Pasalic D, Luetmer PH, Hunt CH, et al. Benign notochordal cell tumor of the sacrum with atypical imaging features: the value of CT guided biopsy for diagnosis. Open Neuroimag J. 2013;7:36–40. doi: 10.2174/1874440001307010036.Pasalic D, Luetmer PH, Hunt CH, et al. Benign notochordal cell tumor of the sacrum with atypical imaging features: the value of CT guided biopsy for diagnosis. Open Neuroimag J. 2013;7:36–40. doi: 10.2174/1874440001307010036.Сидоркин Д.В., Коновалов А.Н., Махмудов У.Б., и др. Хирургическое лечение хордом основания черепа // Вопросы нейрохирургии им. Н.Н. Бурденко. — 2009. — № 2 — С. 15–22.Sidorkin DV, Konovalov AN, Shkarubo AN, et al. Surgical treatment of skull base chordomas. Zh Vopr Neirokhir Im N N Burdenko. 2009;(2):15–22 (In Russ).Сидоркин Д.В., Голанов А.В., Махмудов У.Б. Стереотаксическая радиотерапия на установке Novalis при комбинированном лечении хордом основания черепа // Вопросы нейрохирургии им. Н.Н. Бурденко. — 2010. — № 1 — С. 29–34.Sidorkin DV, Golanov AV, Mahmudov UB. Linear accelerator-based stereotactic radiotherapy in combined treatment of skull base chordomas. Zh Vopr Neirokhir Im N N Burdenko. 2010;(1):29–34.(In Russ).Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. HollandFrei Cancer Medicine [Internet]. 6th ed.; Hamilton (ON): BC Decker; 2003 [cited 2018 Aug 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK12491/Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. HollandFrei Cancer Medicine [Internet]. 6th ed.; Hamilton (ON): BC Decker; 2003 [cited 2018 Aug 3]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK12491/Zhang C, Wang B, Li L, et al. Radioresistance of chordoma cells is associated with the ATM/ATR pathway, in which RAD51 serves as an important downstream effector. Exp Ther Med. 2017;14(3): 2171–2179. doi: 10.3892/etm.2017.4736.Zhang C, Wang B, Li L, et al. Radioresistance of chordoma cells is associated with the ATM/ATR pathway, in which RAD51 serves as an important downstream effector. Exp Ther Med. 2017;14(3): 2171–2179. doi: 10.3892/etm.2017.4736.Штам Т.А., Варфоломеева Е.Ю., Семенова Е.В., Филатов М.В. Влияние уровня экспрессии RAD51-рекомбиназы на выживаемость и прохождение фаз цикла клетками человека // Цитология. — 2008. — Т. 50. — № 11 — С. 958–964.Shtam TA, Varfolomeeva EYu, Semenova EV, Filatov MV. Human RAD51 recombinase: the role in the cell cycle checkpoint and cellular survival. Tsitologiia. 2008;50(11):959–963. (In Russ).Diaz RJ, Cusimano MD. The biological basis for modern treatment of chordoma. J Neuro-oncol. 2011;104(2):411–422. doi: 10.1007/s11060-011-0559-8.Diaz RJ, Cusimano MD. The biological basis for modern treatment of chordoma. J Neuro-oncol. 2011;104(2):411–422. doi: 10.1007/s11060-011-0559-8.Cornelius JF, Eismann L, Ebbert L, et al. 5-Aminolevulinic acidbased photodynamic therapy of chordoma: in vitro experiments on a human tumor cell line. Photodiagnosis Photodyn Ther. 2017;20:111–115. doi: 10.1016/j.pdpdt.2017.09.011.Cornelius JF, Eismann L, Ebbert L, et al. 5-Aminolevulinic acidbased photodynamic therapy of chordoma: in vitro experiments on a human tumor cell line. Photodiagnosis Photodyn Ther. 2017;20:111–115. doi: 10.1016/j.pdpdt.2017.09.011.Табакова С.А. Когда гамма-нож — единственное решение // Здравоохранение Югры: опыт и инновации. — 2015. — № 2 — С. 3–5.Tabakova SA. Kogda gamma-nozh — edinstvennoe reshenie. Zdravoohranenie Yugry: opyt i innovacii. 2015;(2):3–5. (In Russ).

The authors declare that there are no conflicts of interest present.